Introduction
Allo-SCT is the treatment of choice for many hematological, congenital and hereditary diseases. 1 However, the prognosis of allo-SCT is affected by many factors, including GVHD, 2 infections, 3 patient's age, stage of the underlying disease, the number of cells infused and other factors. 4 Socioeconomic status (SeS) has been associated with mortality in different medical settings. A lower SeS is associated with child mortality, 5 death because of cardiovascular disease, 6 ,7 asthma 8 and stroke, 9 and worse survival in breast 10 and colorectal cancer. 11, 12 In renal transplantation, graft rejection increases and graft survival decreases in the lower SeS subgroup. 13 Finally, SeS also influences different outcomes in hematologic malignancies. A lower survival is associated with lower SeS in multiple myeloma 14 and ALL. 15, 16 Data on SCT are scarce. Baker et al. 17 showed a trend toward a higher risk of treatment failure and overall mortality among Hispanic patients with acute and chronic leukemia after conventional BMT, and Karanth et al. 18 showed a higher incidence of acute GVHD and TRM in non-Caucasians submitted to hematopoietic SCT; both authors hypothesized a possible role for SeS in their results. Another study performed in Brazil associated lower income with better overall survival. 19 Our aim in the present study was to determine whether socioeconomic factors, analyzed in a broad manner (considering not only income but also education level and family belongings), had any influence on the outcome of allo-BMT.
To do that, we tested the association among SeS, TRM, overall survival and other outcomes after allo-SCT.
Materials and methods

Patient, donor and transplant characteristics
In total, 201 consecutive patients from December 1994 to April 2007 who received a related HLA-identical allo-SCT were reviewed. Table 1 summarizes their disease and transplant characteristics. Overall, 115 (57%) were men, with a median age of 30 years (range: 0.7-57.1). CMV serology was positive in 141 patients (70%). Overall, 163 patients had malignancies: CML in 68 (34%), acute leukemia in 63 (31%), myelodysplastic syndrome in 12 (6%) and other malignancies in 20 patients (10%). Overall, 38 patients (19%) were transplanted for severe aplastic anemia.
GVHD prophylaxis consisted of the classical combination of CsA and methotrexate in 147 patients (74%). All patients received an unmanipulated graft, with 158 patients (78.6%) patients receiving BM as a stem cell source. Busulfan þ cyclophosphamide were used as conditioning regimen in 115 patients (57%). Thirty-five patients (17.4%) received TBI (12 Gy). A non-myeloablative conditioning regimen was employed in 23 patients (11.1%).
All patients received antifungal and antiviral prophylaxis with fluconazole and acyclovir, respectively, beginning 1 week before marrow transplantation and continuing until the end of systemic immunosuppression. G-CSF was given to the patients who did not reach 500 Â 10 6 neutrophils by day 28 after SCT.
Socioeconomic characteristics
Information regarding SeS of each patient is routinely collected by the Social Services before admission. The SeS variables used comprise income, house characteristics and personal/family belongings and constitute the basis of a classification created by the Brazilian Association of Market Research Agencies, 20 which is used routinely to evaluate the economic classes and market situation in Brazil. Accordingly, SeS is classified into five groups in which groups A and E are formed by the richest and the poorest, respectively, and groups B-D are at an intermediate status.
It does not, however, separate with precision the upper social class categories as it considers predominantly economic strata. What it can do, however, is categorize more precisely the poorest classes (D and E). These lower categories have a low income and consistently poor access to health and education. Owing to the lack of precision in defining social stratification in the upper classes, in our study we divided patients into two broader groups: the richest (A þ B þ C) and the poorest (D þ E). In total, 149 (72%) and 52 (28%) of our patients belonged to the upper and lower classes, respectively.
End point definitions
Neutrophil recovery was defined as the first of three consecutive days with neutrophils more than 0.5 Â 10 9 /l during the first 45 days after transplant. Platelet recovery was defined as the first of 7 days of unsupported platelets more than 20 Â 10 9 /l during the first 180 days after transplant. Acute GVHD was diagnosed and graded according to the Glucksberg criteria, 21 and chronic GVHD was diagnosed according to the Sullivan criteria. 22 All patients were considered evaluable for acute GVHD at day þ 1 after transplant. Occurrence of chronic GVHD was evaluated among patients who survived with sustained engraftment from day þ 100 after transplant. TRM was calculated from transplantation to death related to transplant and not to relapse, during the first 100 days post transplant. Survival was calculated from transplantation to death from any cause.
Statistical analysis
Cumulative incidence of neutrophil and platelet recoveries, time to bacterial, CMV infection/disease, acute (grades 2-4) and chronic GVHD were estimated in a competing risk setting, with death treated as the competing event. Survival analysis (for transplant-related death and overall survival) was calculated using the Kaplan-Meier estimates. The following variables were tested by the log-rank test (for survival) and by the proportional hazards regression model of Fine and Gray (for other outcomes): graft source, diagnosis of BM failure syndrome, diagnosis of CML, diagnosis of acute leukemia, diagnosis of malignancy other than leukemia, early stage of disease (low risk of relapse), use of a radiation-based conditioning, use of busulfan þ cyclophosphamide, use of a non-myeloablative conditioning regimen and SeS categories. Multivariable Cox hazards regression models were then fitted in which all covariates previously selected as having prognostic value at the 20% level were introduced simultaneously with the SeS categories. Variables included in the multivariate analysis for each outcome are shown in Table 2 .
All statistical tests were two-sided, with P-values of 0.05 or less indicating statistical significance. Statistical analyses were performed on SPSS10.0 and Splus2000 software packages.
Results
Neutrophil and platelet recovery
The median time to neutrophil engraftment was 19 days (CI ¼ 9-25). The estimated cumulative incidence of neutrophil engraftment within the first 100 days was 92%. The Acute GVHD The incidence of acute GVHD (II-IV) within the first 100 days was 28.5%. The following cumulative incidence was observed regarding the staging of acute GVHD: 52.9% of the patients had grade 0, 18.6% had grade 1, 14.2% had grade 2, 7.4% had grade 3 and 6.9% had grade 4. The poorest category was significantly associated with a higher risk of acute GVHD in multivariate analysis (HR ¼ 2.62; 95% CI ¼ 1.52-4.52; P ¼ 0.001).
Chronic GVHD
The estimated 5-year cumulative incidence of chronic GVHD was 38%. The staging of the disease was as follows: 32% of the patients had limited disease and 68% had extensive disease grade. The poorest category was significantly associated with a higher incidence of chronic GVHD in multivariate analysis (HR ¼ 2.61; 95% CI ¼ 1.45-4.68; P ¼ 0.001).
Relapse
The 5-year estimated cumulative incidence of relapse was 14.1%. Patients with non-malignant diseases were excluded from the analysis. The poorest group showed a trend to have more relapse (P ¼ 0.17) in multivariate analysis.
TRM
In total, 44 patients (21.9%) died from transplant-related complications within the first 100 days. Figure 1 shows the association between TRM and SeS. The poorest patients showed a significantly higher rate of TRM in multivariate analysis (HR ¼ 1.92; 95% CI ¼ 1.03-3.56; P ¼ 0.039). Figure 1 shows a progressive difference in TRM between the richest and the poorest patients after day 60 of SCT.
Overall survival Survival in 5 years was 55.2% (111 patients). Ninety patients (44.7%) died. Thirteen deaths (14.4%) were due to relapse and 77 deaths (85.5%) were related to various causes: GVHD in 35% of the patients followed by infections (viral, bacterial and fungal) in 33%, bleeding in 10%, rejection in 7 and 15% others. This proportion was maintained in the two socioeconomic groups. Figure 2 shows the association between SeS and 5-year overall survival. The Cox multivariate analysis revealed that the poorest patients showed a positive association with death from any cause (HR ¼ 2.13; 95% CI ¼ 1.39-3.29; P ¼ 0.001). Figure 3 shows that mortality related to SCT was the same in both groups until approximately 60 days, when the curve starts a progressive modification in survival, being statistically significant lower in the D þ E SeS group when compared with the richest SeS group. Table 3 shows all results derived from the multivariate analysis for the end points described below.
Discussion
The prognosis of allogeneic BMT is influenced by many factors, such as patient's and disease characteristics, and clinical complications related to BMT. In this study, we show that an often neglected variable, the SeS, plays a major role on different outcomes after allo-SCT.
Various recent studies showed a socioeconomic influence in mortality rates of different hematological neoplastic diseases and also in SCT. Borato-Viana and co-workers 15, 16 studied the effect of malnutrition and SeS on the outcome of a group of children with ALL and showed a 12-year disease-free survival rate of 59% for richer children with a good nutrition status and 27% for poorer children with a good nutrition status (Po0.001). In our group of patients, there were no differences concerned with nutrition status between the two SeS groups (data not shown).
Alexanian et al. 23 studied the outcome of neoplastic diseases in individuals of different ethnic groups and SeS and showed that poorer patients have a lower survival irrespective of their ethnic group. In their study, the poorest patients treated at the Harlem Hospital had a significantly lower overall survival when compared with the rich black and Caucasian patients treated at the Presbyterian Hospital with the same chemotherapy regimens. Baker et al. 17 showed a trend toward a higher risk of treatment failure and overall mortality among Hispanic patients with acute and chronic leukemia after conventional BMT. However, the results did not show statistically significant differences between Hispanics and white patients. Karanth et al. showed a higher TRM in non-Caucasians undergoing sibling allo-SCT, but in this study the socioeconomic variables were not addressed. In our study, we had no significant differences related to race between the patients, with almost all of them being Caucasian descendants (data not shown). 
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With regard to characteristics of primary disease, Borato-Viana did not find biological (immune phenotypic or karyotypic) differences in the children of different socioeconomic levels with ALL. In addition to the biology of primary disease, the length of time from diagnosis to treatment could negatively affect the SCT prognosis. Advanced diseases require intensive treatments and extensive blood product utilization, and have an increased risk of infections, acute GVHD and relapse. A worse survival in the D þ E group could be related to allo-SCT carried out only after several therapeutic regimens necessary to treat advanced diseases. An earlier study 24 showed that more than 60% of patients with Hodgkin's disease in a third-world population presented with advanced disease (stage III or IV) and B symptoms at diagnosis. Loureiro et al. 25 also showed an increase in a range of 68-78% for advanced Hodgkin's disease at diagnosis, and a delay from the beginning of symptoms to the diagnosis of 5 months in poorer patients was observed by Spector et al. 26 However, we found no significant association between disease stage at diagnosis and survival either in our analysis or in disease status at the time of the transplant, making this hypothesis less likely.
Economic influence seems to be multifactorial. In addition to nutritional issues, racial factors and characteristics of primary disease reviewed above, other issues could explain the association between poverty and a worse overall survival: general sanitary conditions after discharge from hospital, hardship in access to good-quality hospital care, 15 acquisition of costly medications used to treat infectious complications, patient compliance with treatment and the problems in psychological management that is demanded from socioeconomically underprivileged individuals. A single previous Brazilian study correlates lower income with better survival after allo-SCT. However, besides 27 In our center, a lower SeS did not exclude any patient from allo-SCT.
Another variable initially described by Horowitz and Rowlings 28 and recently reviewed by Loberiza et al. 29 is the center effect. In the latter study, the authors studied BMT Centers in the USA, the outcomes of which are reported to Center for International Blood and Marrow Transplant Research (CIBMTR) (formerly International Bone Marrow Transplant Registry (IBMTR)). They concluded that only higher patient per physician ratio, centers where physicians answer calls after office hours, and the presence of students/ residents without fellows were associated with lower 100-day mortality. If such an assumption can also be applied to our center, it would explain the lack of differences in SCT outcome observed during the first decade in which we transplanted 120 patients compared with 80 transplanted patients in the last 3 years. The groups had similar overall survival, TRM, and incidence of acute and chronic GVHD (data not shown). The patient per physician ratio has been maintained at 2:1 over the last 13 years; only in the last 5 years have we had physicians working under a physician's supervision and the physicians are devoted to BMT patients only, being permanently on call after office hours. As stated above, racial differences could also have an impact on SCT outcomes. Baker et al. 17 analyzing ethnic minority outcomes in hematopoietic SCT for acute and chronic leukemias in the US, compared the outcomes for American white and black, Asian and Hispanic patients. Only Hispanics had higher risks of treatment failure (death or relapse and overall mortality). Brazilians are probably classified as Hispanics, and to our knowledge, there is no known study classifying the SeS of Brazilian immigrants. There is, however, a general perception that Brazilian immigrants to the US are predominantly illegal at first, and as such, we could speculate that these individuals in search for a better life belonged to a lower SeS. Rio Grande do Sul was colonized by Germans and Italians. The native population slowly intermarried with the colonizers and at the borders (Uruguay and Argentina) with the Spanish. However, the racial mixture is very impressive: the prevalence of sickle cell anemia trait is 1:65 newborns, 19 and it is as frequent in the predominantly Italian colonized area 30 where thalassemia is not as prevalent. These results have been confirmed all over the state, as over 85% of the newborn population in Rio Grande do Sul is screened for hemoglobinopathies. 31 In our group of patients, we did not find any significant racial difference among the groups (data not shown).
In a recent study, 7 low SeS was related to a higher mortality secondary to cardiovascular disease in the city of Porto Alegre, the capital of Rio Grande do Sul. Among the many variables analyzed, less years of education for the head of the family was one of the major risk factors determining mortality from cardiovascular disease. On the other hand, childhood mortality rate is unfortunately high in the state and is caused by common infectious diseases attributed to poor sanitation, 32 which could have an impact on the variety of antigen exposition affecting this population.
To overcome these SeS variables, the patients in our institution have a day hospital opened for their needs and we provide all necessary drugs for treating infection, and GVHD prophylaxis and treatment. There is also an accommodation facility near the hospital where they stay during the first few weeks after discharge. Nurses and social workers also pay periodic visits to their homes. Unfortunately, these variables are multiple and difficult to control in a retrospective study.
In our study, the D þ E poor SeS group showed an approximately twofold greater chance of dying from any cause in 5 years compared with patients in category C. TRM at 100 days, acute GVHD, chronic GVHD, neutrophil and platelet engraftment were also influenced by SeS.
In conclusion, our study pointed to a relevant role of socioeconomic variables in different outcomes of allo-SCT, at least in developing countries. These results should be confirmed by a multicentric study in Brazil and, if possible, in developed countries as well. Finally, these preliminary data should not influence the decision to transplant lower SeS patients, but it should draw attention to the possibility of complications.
